BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 30361087)

  • 1. Effects of propranolol therapy in Moroccan children with infantile hemangioma.
    Lahrichi A; Hali F; Baline K; Fatoiki FZE; Chiheb S; Khadir K
    Arch Pediatr; 2018 Nov; 25(8):449-451. PubMed ID: 30361087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
    Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
    J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful discontinuation of propranolol for infantile hemangiomas of the head and neck at 12 months of age.
    Hong P; Tammareddi N; Walvekar R; Chiu ES; Poole JC; Kluka EA; Simon LM
    Int J Pediatr Otorhinolaryngol; 2013 Jul; 77(7):1194-7. PubMed ID: 23706952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
    Prasad A; Sinha AK; Kumar B; Prasad A; Kumari M
    Pan Afr Med J; 2019; 32():155. PubMed ID: 31303926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta Blockade as Treatment for Intracranial Infantile Hemangioma: Case Report and Literature Review.
    Kang E; Friedman N; Mamoun I; Tamburro J; Golden A
    Pediatr Neurol; 2016 Jun; 59():13-7. PubMed ID: 27068061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of propranolol for infantile hemangiomas.
    Küpeli S
    Pediatr Hematol Oncol; 2012 Apr; 29(3):293-8. PubMed ID: 22303875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of propranolol treatment for patients with infantile hemangioma.
    Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
    Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
    Kagami S; Kaneko M; Kishi A; Katori T
    J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of poor response to oral propranolol in infantile hemangiomas.
    Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S
    Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of oral propranolol in the treatment of infantile subglottic hemangioma.
    Li XY; Wang Y; Jin L; Chen JR
    Int J Clin Pharmacol Ther; 2016 Sep; 54(9):675-81. PubMed ID: 27285465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.
    Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA
    Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful management of airway hemangioma with propranolol.
    Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
    Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
    Kagami S; Kaneko M; Katori T
    J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
    Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
    Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
    Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
    J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of propranolol in the treatment of parotid hemangioma.
    Morais P; Magina S; Mateus M; Trindade E; Jesus JM; Azevedo F
    Cutan Ocul Toxicol; 2011 Sep; 30(3):245-8. PubMed ID: 21338243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
    Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
    Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.